Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hepatitis
  Free Subscription

Articles published in
Clin Infect Dis
    March 2026
  1. FURUKAWA NW, Kamili S, Wester C
    A Turning Point for Hepatitis C Care: Point-of-Care HCV RNA Authorization as a Critical First Step Towards Integrated Test-and-Treat Models in the United States.
    Clin Infect Dis. 2026 Mar 13:ciag174. doi: 10.1093.
    >> Share

  2. HAVENS JR, Fluker SA, Schimmel J, McCrary LM, et al
    Performance Evaluation of the Xpert(R) HCV test on Fingerstick Blood in a Prospective Observational Clinical Study at CLIA-Waived Sites in the United States.
    Clin Infect Dis. 2026 Mar 13:ciag173. doi: 10.1093.
    >> Share

    February 2026
  3. MOHAREB AM, Boyd A
    Hepatitis B Virus Reactivation in People With HIV After Treatment With Non-hepatitis B virus-active Antiretroviral Therapy.
    Clin Infect Dis. 2026 Feb 24:ciag002. doi: 10.1093.
    >> Share

  4. DENYER RV, Tate JP, Benator DA, Lim JK, et al
    Hepatitis B Reactivation in a US Cohort of People With Human Immunodeficiency Virus and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy Without Hepatitis B Activity.
    Clin Infect Dis. 2026 Feb 24:ciag001. doi: 10.1093.
    >> Share

  5. BIXLER D, Bennett CC, Yin S, Thomson A, et al
    Fatal Overdose, Acute Viral Hepatitis, and Human Immunodeficiency Virus Attributed to Injection Drug Use, Appalachian Region of the United States, 2000-2023.
    Clin Infect Dis. 2026 Feb 11:ciaf730. doi: 10.1093.
    >> Share

    January 2026
  6. FONCILLAS A, Ambrosioni J, Sempere A, Berrocal L, et al
    Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles.
    Clin Infect Dis. 2026 Jan 14:ciag023. doi: 10.1093.
    >> Share

  7. HOFMEISTER MG, Symum H, Swanson BE, Barker LK, et al
    Estimated hepatitis C prevalence and viral clearance using residual sera from a large commercial laboratory-November 2023-September 2024.
    Clin Infect Dis. 2026 Jan 8:ciag007. doi: 10.1093.
    >> Share

    December 2025
  8. MENDLOWITZ AB, Flemming JA, Kushner T, Wong WWL, et al
    Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy.
    Clin Infect Dis. 2025 Dec 9:ciaf578. doi: 10.1093.
    >> Share

    November 2025
  9. OLCOTT F, Oddie PD, Barlow MJ, Mamarelis A, et al
    Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice.
    Clin Infect Dis. 2025 Nov 19:ciaf634. doi: 10.1093.
    >> Share

  10. VAN SANTEN DK, Chalouni M, Berenguer J, Jarrin I, et al
    Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV.
    Clin Infect Dis. 2025 Nov 19:ciaf635. doi: 10.1093.
    >> Share

    September 2025
  11. LO RE V 3RD, Bhattacharya D, Price JC, Aronsohn A, et al
    State-of-the-Art Review: Hepatitis C.
    Clin Infect Dis. 2025;81:e15-e26.
    >> Share

  12. LO RE V 3RD, Bhattacharya D, Price J, Aronsohn A, et al
    Executive Summary: State-of-the-Art Review: Hepatitis C.
    Clin Infect Dis. 2025;81:217-219.
    >> Share

    August 2025
  13. MAKUZA JD, Jeong D, Law M, Puyat JH, et al
    HBV Care Cascade in Rwanda: A Population-based Study From 2016-2023.
    Clin Infect Dis. 2025 Aug 29:ciaf393. doi: 10.1093.
    >> Share

  14. CHAPPELL CA, Brooks KM, Kiser JJ, Klein B, et al
    Sofosbuvir/Velpatasvir Concentrations in the Breastmilk of Postpartum Women with Opioid Use Disorder Receiving Treatment for Hepatitis C Virus: a pharmacokinetic study.
    Clin Infect Dis. 2025 Aug 7:ciaf443. doi: 10.1093.
    >> Share

    July 2025
  15. KIM AY, Kang M, Umbleja T, Nunes EP, et al
    Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.
    Clin Infect Dis. 2025 Jul 30:ciaf305. doi: 10.1093.
    >> Share

  16. BERENGUER J, Fanciulli C, Arcos MM, Vivancos MJ, et al
    Trends in HCV Infection Prevalence Among People with HIV in Spain Over Two Decades (2002-2023).
    Clin Infect Dis. 2025 Jul 24:ciaf407. doi: 10.1093.
    >> Share

  17. WOODHOUSE EW, Henson JB, Yarrington ME, Lushniak L, et al
    Take It Off the Back Burner-Missed Opportunities to Treat Hepatitis C Virus (HCV) Inpatients.
    Clin Infect Dis. 2025 Jul 23:ciaf303. doi: 10.1093.
    >> Share

  18. GREBELY J
    Right test for the right patient in the right setting: Enhancing testing and treatment for hepatitis C infection among people who inject drugs.
    Clin Infect Dis. 2025 Jul 15:ciaf367. doi: 10.1093.
    >> Share

  19. ZHU L, Furukawa NW, Thompson WW, Reitsma MB, et al
    Potential impact of frequent testing for hepatitis C virus among people who inject drugs toward hepatitis C elimination in the United States.
    Clin Infect Dis. 2025 Jul 15:ciaf368. doi: 10.1093.
    >> Share

  20. PRASAD M, Sandoval GJ, Saade GR, Hughes BL, et al
    Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C Virus.
    Clin Infect Dis. 2025 Jul 14:ciaf266. doi: 10.1093.
    >> Share

  21. GRIFFIN S, Asselin J, Wilkinson AL, Traeger MW, et al
    The hepatitis C cascade of care for opioid agonist therapy recipients in Australia.
    Clin Infect Dis. 2025 Jul 9:ciaf352. doi: 10.1093.
    >> Share

    May 2025
  22. AUDSLEY J, Avihingsanon A, Li X, Edwards R, et al
    Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and chronic HBV co-infection.
    Clin Infect Dis. 2025 May 31:ciaf281. doi: 10.1093.
    >> Share

  23. HALL EW, Sandul AL, Kamili S, Cartwright EJ, et al
    Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults.
    Clin Infect Dis. 2025 May 21:ciaf166. doi: 10.1093.
    >> Share

  24. KU JH, Gu YM, Hoke CF, Tseng HF, et al
    Screening and vaccination rates for tetanus, hepatitis A, and hepatitis B among individuals with substance use disorders who are hospitalized in an integrated U.S. health system.
    Clin Infect Dis. 2025 May 20:ciaf251. doi: 10.1093.
    >> Share

    April 2025
  25. SHEMUEL J, Krawiec A, Kalauokalani D, Lucas KD, et al
    A Case-Control Study of Hepatitis C Virus Re-infection in Incarcerated Patients in California Receiving Medication for Opioid Use Disorder.
    Clin Infect Dis. 2025 Apr 15:ciaf192. doi: 10.1093.
    >> Share

  26. THOMAS AM, Litwin AH, Tsui JI, Sprecht-Walsh S, et al
    Retreatment of Hepatitis C Virus Among People Who Inject Drugs.
    Clin Infect Dis. 2025 Apr 15:ciaf082. doi: 10.1093.
    >> Share

  27. CARSON JM, Dore GJ
    Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who Inject Drugs.
    Clin Infect Dis. 2025 Apr 15:ciaf083. doi: 10.1093.
    >> Share

  28. TOY M, Hutton D, Teshale E, Thompson WW, et al
    Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States.
    Clin Infect Dis. 2025 Apr 8:ciaf181. doi: 10.1093.
    >> Share

  29. DAVY-MENDEZ T, Napravnik S, Hogan BC, Eron JJ, et al
    Changes in the prevalence of non-AIDS conditions among hospitalized persons with HIV in the United States and Canada, 2008-2018.
    Clin Infect Dis. 2025 Apr 2:ciaf167. doi: 10.1093.
    >> Share

    February 2025
  30. AZZELLINO G, Ginaldi L, De Martinis M
    A Biosocial Roadmap to Tackle the Burden of Hepatitis C Virus Infections That Ensures Health Equity for All.
    Clin Infect Dis. 2025 Feb 12:ciae623. doi: 10.1093.
    >> Share

    January 2025
  31. SERUMONDO J, Barebwanuwe P, Sheferaw ED, Iyonizera J, et al
    Introducing Sofosbuvir/Velpatasvir + Ribavirin as a Generic Retreatment Regimen for Hepatitis C: Evaluation of a Government Program in Rwanda.
    Clin Infect Dis. 2025 Jan 29:ciae637. doi: 10.1093.
    >> Share

  32. BARRE T, Ramier C, Wittkop L, Sogni P, et al
    Low CD4 cell count is associated with post-hepatitis C virus cure mortality in people living with HIV (ANRS CO13 HEPAVIH cohort).
    Clin Infect Dis. 2025 Jan 15:ciaf016. doi: 10.1093.
    >> Share

  33. MATELSKI A, Gregoire B, Beste LA, Varley CD, et al
    Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of U.S. Veterans.
    Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093.
    >> Share

  34. HUANG YS, Sun HY, Ho SY, Lin KY, et al
    Incidence and outcome of hepatitis D virus infection in people with HIV in the era of tenofovir-containing antiretroviral therapy.
    Clin Infect Dis. 2025 Jan 2:ciae655. doi: 10.1093.
    >> Share

    December 2024
  35. HAN WM, Solomon S, Smeaton L, Avihingsanon A, et al
    Reinfection and resistance associated substitutions following a minimal monitoring approach for HCV treatment in MINMON trial.
    Clin Infect Dis. 2024 Dec 20:ciae627. doi: 10.1093.
    >> Share

  36. CHAPPELL CA, Kiser JJ, Brooks KM, Randolph R, et al
    Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus.
    Clin Infect Dis. 2024 Dec 17:ciae595. doi: 10.1093.
    >> Share

    November 2024
  37. SEAMAN A, Cook R, Leichtling G, Herink MC, et al
    Peer-assisted telemedicine for hepatitis C in people who use drugs: A randomized controlled trial.
    Clin Infect Dis. 2024 Nov 27:ciae520. doi: 10.1093.
    >> Share

  38. AKIYAMA MJ, Thornton K, Voyles N, Vincent L, et al
    Meeting People Where They Are: The Roles of Peer Navigation and Telemedicine for HCV Elimination.
    Clin Infect Dis. 2024 Nov 27:ciae521. doi: 10.1093.
    >> Share

  39. PERERA H, Keeshan A, Imsirovic H, Patern J, et al
    Rapid HCV Engagement and Treatment in Hospitalized Patients.
    Clin Infect Dis. 2024 Nov 21:ciae574. doi: 10.1093.
    >> Share

  40. EPSTEIN RL, Munroe S, Taylor LE, Duryea PR, et al
    Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study.
    Clin Infect Dis. 2024 Nov 13:ciae485. doi: 10.1093.
    >> Share

    October 2024
  41. INZAULE S, Easterbrook P, Latona A, Ford NP, et al
    Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2024 Oct 3:ciae431. doi: 10.1093.
    >> Share

  42. BIONDI BE, Munroe S, Lavarin C, Curtis MR, et al
    Racial and Ethnic Disparities in Hepatitis C Care in Reproductive-Aged Women With Opioid Use Disorder.
    Clin Infect Dis. 2024 Oct 2:ciae426. doi: 10.1093.
    >> Share

    September 2024
  43. MARTIN-CARMONA J, Corma-Gomez A, Tellez F, Arenga-Barrios D, et al
    No impact of HIV coinfection on the mortality in patients with hepatitis C virus infection after sustained virological response.
    Clin Infect Dis. 2024 Sep 18:ciae473. doi: 10.1093.
    >> Share

  44. MACISAAC MB, Papaluca T, McDonald L, Craigie A, et al
    Long-term outcomes of a decentralized, nurse-led, statewide model of care for hepatitis C among people in prison in Victoria, Australia.
    Clin Infect Dis. 2024 Sep 16:ciae471. doi: 10.1093.
    >> Share

    July 2024
  45. FRIEDMAN JR, Abramovitz D, Skaathun B, Rangel G, et al
    Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.
    Clin Infect Dis. 2024 Jul 30:ciae372. doi: 10.1093.
    >> Share

  46. FIERER DS, Carollo JR, Rodriguez-Caprio G, Radix A, et al
    Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City.
    Clin Infect Dis. 2024 Jul 18:ciae297. doi: 10.1093.
    >> Share

    June 2024
  47. RUSS RK, Vandehei HM, Golovkina MI, Mogallapalli H, et al
    Hepatitis B-CpG vaccine series for healthcare workers who are hepatitis B vaccine nonresponders.
    Clin Infect Dis. 2024 Jun 17:ciae320. doi: 10.1093.
    >> Share

  48. MIDGARD H, Malme KB, Finbraten AK, Dalgard O, et al
    Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins?
    Clin Infect Dis. 2024 Jun 2:ciae298. doi: 10.1093.
    >> Share

    May 2024
  49. PAN CQ, Zhu L, Yu AS, Zhao Y, et al
    Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2024 May 28:ciae288. doi: 10.1093.
    >> Share

  50. LO RE V 3RD, Price JC, Schmitt S, Terrault N, et al
    The Obstacle is the Way: Finding a Path to Hepatitis C Elimination.
    Clin Infect Dis. 2024 May 16:ciae231. doi: 10.1093.
    >> Share

  51. ZHANG HL, Mock M, Bushman L, Anderson PL, et al
    Cumulative tenofovir exposure among patients with human immunodeficiency virus/hepatitis B co-infection with differential viral suppression.
    Clin Infect Dis. 2024 May 3:ciae241. doi: 10.1093.
    >> Share

    April 2024
  52. HOOD RB, Norris AH, Shoben A, Miller WC, et al
    Forecasting Hepatitis C Virus Status for Children in the United States: A Modeling Study.
    Clin Infect Dis. 2024 Apr 17:ciae157. doi: 10.1093.
    >> Share

  53. CAFARDI JM, Lin HT, Lange L, Kelley L, et al
    Vertical Transmission of Hepatitis C Virus Among Women with a History of Injection Opioid Use.
    Clin Infect Dis. 2024 Apr 5:ciae177. doi: 10.1093.
    >> Share

  54. SU WJ, Chen HL, Chen SF, Liu YL, et al
    Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing.
    Clin Infect Dis. 2024 Apr 2:ciae176. doi: 10.1093.
    >> Share

    March 2024
  55. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
    Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
    Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
    >> Share

  56. GREBELY J
    Point-of-care testing for hepatitis C infection: A critical building block for the foundation to achieve elimination.
    Clin Infect Dis. 2024 Mar 21:ciae156. doi: 10.1093.
    >> Share

  57. MCCARTNEY EM, Ralton L, Dawe J, Richmond J, et al
    Point of care testing for hepatitis C in the priority settings of mental health, prisons and drug & alcohol facilities - the PROMPt Study.
    Clin Infect Dis. 2024 Mar 21:ciae155. doi: 10.1093.
    >> Share

    February 2024

  58. Correction to: Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017-March 2020.
    Clin Infect Dis. 2024 Feb 23:ciad783. doi: 10.1093.
    >> Share

    January 2024
  59. LITWIN AH, Akiyama MJ
    US Veterans Health Administration Hepatitis C Virus (HCV) Program - A Model for National HCV Elimination though Patient-Centered Medical Homes.
    Clin Infect Dis. 2024 Jan 27:ciae028. doi: 10.1093.
    >> Share

  60. VARLEY CD, Lowy E, Cartwright EJ, Morgan TR, et al
    Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.
    Clin Infect Dis. 2024 Jan 27:ciae025. doi: 10.1093.
    >> Share

    November 2023
  61. VINIKOOR MJ, Hamusonde K, Muula G, Asombang M, et al
    Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia.
    Clin Infect Dis. 2023 Nov 24:ciad654. doi: 10.1093.
    >> Share

  62. MIDGARD H, Malme KB, Pihl CM, Berg-Pedersen RM, et al
    Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial.
    Clin Infect Dis. 2023 Nov 22:ciad711. doi: 10.1093.
    >> Share

  63. ROWAN SE, Wyles DL
    Don't put off until tomorrow what you can do today: Hospital admissions as an opportunity to treat hepatitis C.
    Clin Infect Dis. 2023 Nov 22:ciad712. doi: 10.1093.
    >> Share

    October 2023
  64. WONG RJ, Yang Z, Cheung R
    Disparities in Antiviral Treatment among Adults with Hepatitis B Cirrhosis: An Analysis of the National Veterans Affairs Cohort.
    Clin Infect Dis. 2023 Oct 9:ciad617. doi: 10.1093.
    >> Share

    September 2023
  65. YANG J, Lo NC, Dankwa EA, Donnelly CA, et al
    Determining herd immunity thresholds for hepatitis A virus transmission to inform vaccination strategies among people who inject drugs in 16 U.S. States.
    Clin Infect Dis. 2023 Sep 21:ciad552. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016